In addition to providing direct care and consultation services across the entire range of primary diagnoses we treat, the position will specifically be part of a new program within CTTS dedicated to the care of patients with severe immune regulatory disorders, and applicant responsibilities will include providing expert consultant continuity of care for these patients both pre- and post-cellular therapy when they are admitted to the hospital, regardless of primary service of record. Areas of research include alternative donor transplants, CAR T cells, transplant for non-malignant diseases including immune regulatory disorders, and other cell therapies.